Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by TM Marsh
Metabolic Evaluation of Study M05-730: LPV/r Tablets QD vs. BID, Co-Administered With Tenofovir DF + Emtricitabine in ARV-naïve HIV-1 Infected Subjects
Journal of the International AIDS Society
Environmental
Public Health
Infectious Diseases
Occupational Health
Related publications
Resistance Analysis of Bictegravir/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment-Naïve Patients Through 48 Weeks
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
HIV Patients' Gastrointestinal Tolerability and Treatment Satisfaction After Switching From Lopinavir/Ritonavir (LPV/r) SGC to Co-Formulated LPV/r Tablets
Journal of the International AIDS Society
Environmental
Public Health
Infectious Diseases
Occupational Health
Potential Long-Term Cost Savings in Treatment of Naïve Hiv-Infected Patients With Rilpivirine/ Tenofovir/ Emtricitabine (Single Tablet Regimen) in the Russian Federation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
96-Week Results of Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Plus Efavirenz, in Antiretroviral-Naive, HIV-1-infected Adults: ASSERT Study
Antiviral Therapy
Infectious Diseases
Pharmacology
Pharmacokinetic and Safety Analyses of Tenofovir and Tenofovir-Emtricitabine Vaginal Tablets in Pigtailed Macaques
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Abacavir–Lamivudine Versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy
New England Journal of Medicine
Medicine
Switch From a ZDV/3TC-based Regimen to a Completely Once Daily (QD) Regimen of Emtricitabine/Tenofovir DF Fixed Dose Combination Plus a Third QD Agent (SONETT)
European Journal of Medical Research
Medicine
Correction of Metabolic Disorders in Patients Co-Infected With HIV/HCV
ScienceRise
Is Tenofovir/Emtricitabine Teratogenic?
Therapeutic Advances in Drug Safety
Pharmacology
